Source: European Medicines Agency (EU) Revision Year: 2025 Publisher: Bayer AG, 51368 Leverkusen, Germany
Lynkuet 60 mg soft capsules.
| Pharmaceutical Form |
|---|
|
Soft capsule (capsule). Opaque red, oblong, approximately 24 mm long and 11 mm in diameter, with white printing of "EZN60". |
Each soft capsule contains 60 mg elinzanetant.
Excipient with known effect:
Each soft capsule contains 71 mg sorbitol (E420).
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Elinzanetant is a non-hormonal, selective neurokinin 1 (NK-1) and 3 (NK-3) receptors antagonist. It blocks NK-1 and NK-3 receptors signalling on kisspeptin/neurokinin B/dynorphin (KNDy) neurons, which is postulated to normalise neuronal activity involved in thermo- and sleep regulation. |
| List of Excipients |
|---|
|
Capsule filling: All-rac-α-tocopherol (E307) Capsule shell: Gelatin Printing ink: Macrogol 400 (E1521) |
PVC/PCTFE-Aluminium/PET/paper blister containing 12 soft capsules (6 × 2 as unit dose).
Each pack contains 24 or 60 soft capsules.
Each multipack contains 180 (3 packs of 60) soft capsules.
Not all pack sizes may be marketed.
Bayer AG, 51368 Leverkusen, Germany
EU/1/25/1991/001 - Lynkuet 60 mg - 24 soft capsules
EU/1/25/1991/002 - Lynkuet 60 mg - 60 soft capsules
EU/1/25/1991/003 - Lynkuet 60 mg - 180 soft capsules
| Drug | Countries | |
|---|---|---|
| LYNKUET | Austria, Estonia, Lithuania, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.